12 results about "Intermediate cell" patented technology

The present invention relates to a method, preferably a computer-implemented method, and to an apparatus for generating at least one intermediate cellular state of a cellular state evolution from an initial cellular state to a corresponding advanced cellular state. The present invention also relates to a computer program for generating at least one intermediate cellular state and to a non-transitory computer readable data medium storing the computer program. Moreover, the present invention relates to a method and to an apparatus for training a model for generating at least one intermediate cellular state of a cellular state evolution from an initial cellular state to a corresponding advanced cellular state. The present invention also relates to a computer program for training a model for generating at least one intermediate cellular state and to a non-transitory computer readable data medium storing the computer program. Furthermore, the present invention relates to a method for diagnosing a disease and forecasting patients' future clinical outcome making use of the method for generating at least one intermediate cellular state. Moreover, the present invention relates to an in-vitro method for transforming the identity of a cell.

The present application belongs to the technical field of biomaterial preparation, and particularly relates to a preparation method of a self-oxygen-supplying hydrogel cell scaffold, the obtained product and application. The present application realizes stable and continuous release of oxygen and three-dimensional (3D) culture of neural stem cell spheres. The method is realized through the following steps: compounds P-MA, P-Cys, ColMA and PEG-CaO2 are added to a PBS solution, a photoinitiator is added, and a'self-oxygen-supplying' composite hydrogel is obtained by irradiation with ultraviolet light of a wavelength of 365 nm. The present application provides a composite hydrogel loaded with oxygen-producing nanoparticles for 3D cell sphere culture and a new method for continuous release of O2 in a slightly acidic environment, aiming at the problems of intermediate cell death caused by hypoxia in the process of 3D culture of existing cell spheres, unclear matrigel composition, high price and the like. The present application solves the problem of internal hypoxia in the process of cell sphere culture, and clearly defines the gel composition for studying the interaction between other components and cells. In addition, the self-oxygen-supplying hydrogel material prepared by the technology is expected to be applied to 3D culture of other cell spheres or organoid spheres.

The present invention relates to a cell intermediate element (2) with gas-filled or evacuated internal cavities (14) and to a method for producing such a cell intermediate element (2). The invention particularly relates to sealing the cavities (14) against the environment. The cell intermediate element (2) comprises: - a first covering layer (3), - a second covering layer (4), - an elastically deformable elastomer intermediate layer formed between the first cover layer (3) and the second cover layer (4). The intermediate cell element (2) comprises an outer shell made of a flexible film or a coating (12) is applied to seal the cavities (14) against the environment.

The application discloses a novel dye-sensitized solar cell optimization method, and relates to the technical field of semiconductor devices, and comprises the following steps: on the basis of a dye-sensitized solar cell model, first, the material of a hole transport layer of the dye-sensitized solar cell model is changed, a plurality of first cell models are obtained correspondingly, and performance simulation is performed; based on the performance simulation result, an intermediate cell model is selected from the plurality of first cell models; then, the electrode material of the intermediate cell model is changed, a plurality of second cell models are obtained correspondingly, and performance simulation is performed; based on the performance simulation result, a to-be-adjusted cell model is selected from the plurality of second cell models; finally, a plurality of adjustable parameters of the to-be-adjusted cell model are optimized, and a target cell model is obtained. Through optimization of the material of the hole transport layer, the material of the electrode and the numerical value of part of the adjustable parameters of the dye-sensitized solar cell model, the performance of a solar cell corresponding to the dye-sensitized solar cell model can be improved.

The invention discloses a preparation method and application of renal progenitor cells. The method specifically comprises the following steps: inducing pluripotent stem cells to be differentiated into an intermediate mesoderm cell stage through a GSK-3alpha / beta inhibitor, and inducing cells in the intermediate mesoderm cell stage to be differentiated into a cap-like mesenchymal stage by using a nuclear receptor agonist containing FGF-2 and RAR / RXR, so as to obtain the renal progenitor cells with obvious specific characteristics and potentials of the cap-like mesenchymal. According to the method, the high-purity and high-quality renal progenitor cells can be obtained without separation and purification, the purity can reach 99.9%, and the obtained renal progenitor cells have the differentiation potential of kidney-like organs, basically have no PSCs residues, have the differentiation potential of kidney-like organs and are suitable for clinical cell therapy; and the operation is simple, stable and controllable, and safe, effective, high-purity and homogeneous renal progenitor cells can be prepared on a large scale.

An in vitro method of producing a population of cells comprising the steps of introducing a source of cells into the first cell culture chamber of an in vitro cell culture vessel comprising three cell culture chambers arranged in a series, each chamber being separated from the next chamber in the series by a semipermeable barrier; contacting the cells in the first cell culture chamber to a first composition of one or more cell growth factors, cell activating factors, cell differentiation factors, cytokines and cell attractants so as to promote migration of at least a subset of cells from the first cell culture chamber into an intermediate cell culture chamber of the series; and contacting cells in the intermediate cell culture chamber of the series to a further composition of one or more cell growth factors, cell activating factors, cell differentiation factors, cytokines and cell attractants so as to promote migration of at least a subset of cells from the intermediate cell culture chamber to the final cell culture chambers in the series. Also related cell culture vessels, cell populations and methods of using cell populations.

Cell block (1) for a battery (2), comprising a plurality of electrochemical individual cells (3) electrically connected in series and / or parallel, which are designed as flat cells, are aligned parallel to each other and arranged one behind the other in the cell block (1) and are clamped together by means of at least one clamping element (11), wherein an intermediate cell holder (9) made of an electrically insulating material is arranged between each pair of adjacent individual cells (3), which has a partition (22) that runs between the respective two adjacent individual cells (3), and wherein a temperature control plate (16) is arranged on at least one longitudinal side of the cell block (1), with which the individual cells (3) are thermally coupled.wherein a cross-section of the partitions (22) of the intermediate cell holders (9) in an edge region (28) facing the temperature control plate (16) is enlarged compared to a cross-section in a central region (29) of the respective partition (22), with at least one end cell holder (10) made of an electrically insulating material at an end face of the cell block (1), wherein the end cell holder (10) has a partition (22) which covers an adjacent single cell (3), wherein a cross-section of the partition (22) in an edge region (28) facing the temperature control plate (16) is enlarged compared to a cross-section in a central region (29) of the respective partition (22), wherein this cross-sectional enlargement extends in the direction of the adjacent single cell (3), characterized in thatthat the intermediate cell holders (9) have side edges (23) on the edges running perpendicular to the edge region (28) facing the temperature plate (16), which each project beyond half of the adjacent individual cells (3), so that the respective side edges (23) of adjacent intermediate cell holders (9) touch, and wherein the end cell holder (10) has side edges (23) on the edges running perpendicular to the edge region (28) facing the temperature plate (16), which project beyond half of the adjacent individual cells (3), so that the side edges (23) of the end cell holder (10) and of the adjacent intermediate cell holder (9) touch.

The invention relates to an energy storage device (1) for storing electrical energy for a motor vehicle (14), comprising several stacked storage cells (3), preferably prismatic storage cells (3). An intermediate cell layer (2) is arranged between each pair of adjacent storage cells (3). The intermediate cell layer has a spacer (4) and a compression element (5), preferably a compression pad, wherein the spacer (4) has a higher thermal conductivity and a lower compressibility compared to the compression element (5). The compression element (5) is dimensioned and arranged relative to the spacer (4) such that at least one side (6) of the spacer (4), which faces one of the two adjacent storage cells (3), is completely covered by the compression element (5). The invention further relates to a motor vehicle (14) comprising such an energy storage device (1).

One embodiment of the semiconductor device comprises a first circuit cell and a second circuit cell, the latter adjoining the first circuit cell at an intermediate cell boundary. The first circuit cell has one or more first conductive traces in a first metallization region of a first metallization layer and has one or more first vias beneath the first metallization layer. The second circuit cell has one or more second conductive traces in a second metallization region of the first metallization layer and has one or more second vias beneath the first metallization layer. The first metallization region and the second metallization region are spaced apart by a common space and extend along the cell boundary.The one or more first via structures and the one or more second via structures are located within an area with a zigzag structure along the cell boundary.

The present invention discloses a portable energy storage battery structure, comprising an upper bracket, a lower bracket, and a cell mechanism embedded in the upper bracket and the lower bracket. The cell mechanism comprises side cell groups located on both sides and a plurality of intermediate cell groups located in the middle. The side cell groups on both sides are respectively connected to the total positive electrode or the total negative electrode of the cell mechanism via a first nickel sheet. The first nickel sheet has a bent double-layer structure, and the plurality of intermediate cell groups of the cell mechanism are respectively connected to a second nickel sheet. By designing the first nickel sheet as a bent double-layer structure, the nickel sheet converges evenly, so that the current of the total positive electrode or the total negative electrode converges toward the bend of the first nickel sheet. This bent double-layer process ensures that the cell will not be overloaded, and the temperature of the cell and the nickel sheet does not exceed the maximum temperature of the cell, thereby ensuring the reliability of the entire battery system.

The invention relates to a culture method of TIL from pleural effusion and / or ascites. Specifically, the invention provides the in-vitro culture method of the pleural effusion and / or ascites derived TIL, and the method comprises the following steps: 1) obtaining TIL seed cells from pleural effusion and / or ascites, and 2) sorting the TIL seed cells to obtain intermediate cells which are CD45RA-cells, CD39 + cells, or CD45RA-CD39 + cells.

Systems and methods for secure portals between virtual worlds are provided. In some embodiments, the systems and methods include deploying a secure portal between two virtual worlds. This is performed by rendering a top cell for a first virtual world. Rendering includes a transparent region overlapping a portal. Then an intermediate cell is layered underneath the top cell. This intermediate cell comprises the portal. A message is received from the top cell. The message includes a minimum rendering size, shape and at least one transform. This message is transferred to a bottom cell for a second virtual world, where it is rendered (in part) responsive to the message. The top cell, the intermediate cell and the bottom cell are then layered to generate a scene. In some embodiments, the rendered portion of the bottom cell comports to the minimum rendering size, and the intermediate cell is transparent. In some cases, the cells are either iFrames, or separate applications.